サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：レッドバイオテクノロジー市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
市場調査レポート
商品コード
1140657

レッドバイオテクノロジー市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

Red Biotechnology Market (Application: Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, and Genetic Testing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 176 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
レッドバイオテクノロジー市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
出版日: 2022年08月16日
発行: Transparency Market Research
ページ情報: 英文 176 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のレッドバイオテクノロジー市場について調査し、市場の概要とともに、2022年～2031年の予測、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 前提と調査手法

第3章 エグゼクティブサマリー：世界のレッドバイオテクノロジー市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界のレッドバイオテクノロジー市場の分析と予測、2017年～2031年

第5章 主な洞察

第6章 世界のレッドバイオテクノロジー市場の分析と予測、用途別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、用途別、2017年～2031年
    • バイオ医薬品製造
    • ファーマコゲノミクス
    • 遺伝子治療
    • 遺伝子検査
  • 用途別の市場魅力分析

第7章 世界のレッドバイオテクノロジー市場の分析と予測、エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、エンドユーザー別、2017年～2031年
    • バイオ医薬品業界
    • CMO・CRO
    • 調査
    • その他
  • エンドユーザー別の市場魅力分析

第8章 世界のレッドバイオテクノロジー市場の分析と予測、地域別

  • 主な調査結果
  • 市場価値予測、地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 地域別の市場魅力分析

第9章 北米のレッドバイオテクノロジー市場の分析と予測

第10章 欧州のレッドバイオテクノロジー市場の分析と予測

第11章 アジア太平洋のレッドバイオテクノロジー市場の分析と予測

第12章 ラテンアメリカのレッドバイオテクノロジー市場の分析と予測

第13章 中東・アフリカのレッドバイオテクノロジー市場の分析と予測

第14章 競合情勢

  • 市場参入企業 - 競合マトリクス（層および企業規模別）
  • 市場シェア分析、企業別、2021年
  • 企業プロファイル
    • Pfizer, Inc.
    • Biogen, Inc.
    • Amgen, Inc.
    • AstraZeneca plc
    • Gilead Sciences, Inc.
    • Celgene Corporation（Bristol-Myers Squibb Company）
    • F. Hoffmann-La Roche, Ltd.
    • Merck KGaA
    • Regeneron Pharmaceuticals, Inc.
    • Takeda Pharmaceutical Company Limited
図表

List of Tables

  • Table 01: Global Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 02: Global Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031
  • Table 03: Global Red Biotechnology Market Value (US$ Bn) Forecast, by Region, 2022-2031
  • Table 04: North America Red Biotechnology Market Value (US$ Bn) Forecast, by Country, 2022-2031
  • Table 05: North America Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 06: North America Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031
  • Table 07: Europe Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2022-2031
  • Table 08: Europe Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 09: Europe Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031
  • Table 10: Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2022-2031
  • Table 11: Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 12: Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031
  • Table 13: Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2022-2031
  • Table 14: Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 15: Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031
  • Table 16: Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2022-2031
  • Table 17: Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 18: Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031

List of Figures

  • Figure 01: Global Red Biotechnology Market Value (US$ Bn) Forecast, 2022-2031
  • Figure 02: Global Red Biotechnology Market Value Share (%), by Application, 2021
  • Figure 03: Global Red Biotechnology Market Value Share (%), by End-user, 2021
  • Figure 04: Global Red Biotechnology Market Value Share (%), by Region, 2021
  • Figure 05: Global Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 06: Global Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 07: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Biopharmaceutical Production, 2022-2031
  • Figure 08: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Gene Therapy, 2022-2031
  • Figure 09: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Pharmacogenomics, 2022-2031
  • Figure 10: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Genetic Testing, 2022-2031
  • Figure 11: Global Red Biotechnology Market Value Share Analysis, by End-user, 2021-2031
  • Figure 12: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Biopharmaceutical Industry, 2022-2031
  • Figure 13: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by CMO & CRO, 2022-2031
  • Figure 14: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Research Institutes, 2022-2031
  • Figure 15: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Others, 2022-2031
  • Figure 16: Global Red Biotechnology Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 17: Global Red Biotechnology Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 18: Global Red Biotechnology Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 19: North America Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 20: North America Red Biotechnology Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 21: North America Red Biotechnology Market Attractiveness Analysis, by Country, 2021-2031
  • Figure 22: North America Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 23: North America Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 24: North America Red Biotechnology Market Value Share Analysis, by End-user, 2021-2031
  • Figure 25: North America Red Biotechnology Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 26: Europe Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 27: Europe Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 28: Europe Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 29: Europe Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 30: Europe Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 31: Europe Red Biotechnology Market Value Share Analysis, by End-user, 2022-2031
  • Figure 32: Europe Red Biotechnology Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 33: Asia Pacific Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 34: Asia Pacific Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 35: Asia Pacific Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 36: Asia Pacific Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 37: Asia Pacific Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 38: Asia Pacific Red Biotechnology Market Value Share Analysis, by End-user, 2022-2031
  • Figure 39: Asia Pacific Red Biotechnology Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 40: Latin America Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 41: Latin America Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 42: Latin America Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 43: Latin America Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 44: Latin America Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 45: Latin America Red Biotechnology Market Value Share Analysis, by End-user, 2022-2031
  • Figure 46: Latin America Red Biotechnology Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 47: Middle East & Africa Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 48: Middle East & Africa Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 49: Middle East & Africa Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 50: Middle East & Africa Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 51: Middle East & Africa Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 52: Middle East & Africa Red Biotechnology Market Value Share Analysis, by End-user, 2022-2031
  • Figure 53: Middle East & Africa Red Biotechnology Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 54: Global Red Biotechnology Market Share, by Company, 2021
目次
Product Code: TMRGL2063

The report provides revenue of the global red biotechnology market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global red biotechnology market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the red biotechnology market.

The report delves into the competitive landscape of the global red biotechnology market. Key players operating in the global red biotechnology market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global red biotechnology market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Red Biotechnology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Red Biotechnology Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Reimbursement Scenario by Region/globally
  • 5.3. Key Industry Events (merger & acquisitions)
  • 5.4. Covid-19 Impact Analysis

6. Global Red Biotechnology Market Analysis and Forecast, by Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Application, 2017-2031
    • 6.3.1. Biopharmaceutical Production
    • 6.3.2. Pharmacogenomics
    • 6.3.3. Gene Therapy
    • 6.3.4. Genetic Testing
  • 6.4. Market Attractiveness Analysis, by Application

7. Global Red Biotechnology Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Biopharmaceutical Industry
    • 7.3.2. CMO & CRO
    • 7.3.3. Research Institutes
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Red Biotechnology Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Red Biotechnology Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Application, 2017-2031
    • 9.2.1. Biopharmaceutical Production
    • 9.2.2. Pharmacogenomics
    • 9.2.3. Gene Therapy
    • 9.2.4. Genetic Testing
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Biopharmaceutical Industry
    • 9.3.2. CMO & CRO
    • 9.3.3. Research Institutes
    • 9.3.4. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Application
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Red Biotechnology Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Application, 2017-2031
    • 10.2.1. Biopharmaceutical Production
    • 10.2.2. Pharmacogenomics
    • 10.2.3. Gene Therapy
    • 10.2.4. Genetic Testing
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Biopharmaceutical Industry
    • 10.3.2. CMO & CRO
    • 10.3.3. Research Institutes
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Application
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Red Biotechnology Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Application, 2017-2031
    • 11.2.1. Biopharmaceutical Production
    • 11.2.2. Pharmacogenomics
    • 11.2.3. Gene Therapy
    • 11.2.4. Genetic Testing
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Biopharmaceutical Industry
    • 11.3.2. CMO & CRO
    • 11.3.3. Research Institutes
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. India
    • 11.4.3. Japan
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Application
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Red Biotechnology Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Application, 2017-2031
    • 12.2.1. Biopharmaceutical Production
    • 12.2.2. Pharmacogenomics
    • 12.2.3. Gene Therapy
    • 12.2.4. Genetic Testing
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Biopharmaceutical Industry
    • 12.3.2. CMO & CRO
    • 12.3.3. Research Institutes
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Application
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Red Biotechnology Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Application, 2017-2031
    • 13.2.1. Biopharmaceutical Production
    • 13.2.2. Pharmacogenomics
    • 13.2.3. Gene Therapy
    • 13.2.4. Genetic Testing
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Biopharmaceutical Industry
    • 13.3.2. CMO & CRO
    • 13.3.3. Research Institutes
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Application
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2021
  • 14.3. Company Profiles
    • 14.3.1. Pfizer, Inc.
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. Business Strategies
      • 14.3.1.5. Recent Developments
    • 14.3.2. Biogen, Inc.
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. Business Strategies
      • 14.3.2.5. Recent Developments
    • 14.3.3. Amgen, Inc.
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. Business Strategies
      • 14.3.3.5. Recent Developments
    • 14.3.4. AstraZeneca plc
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. Business Strategies
      • 14.3.4.5. Recent Developments
    • 14.3.5. Gilead Sciences, Inc.
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Financial Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. Business Strategies
      • 14.3.5.5. Recent Developments
    • 14.3.6. Celgene Corporation (Bristol-Myers Squibb Company)
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. Business Strategies
      • 14.3.6.5. Recent Developments
    • 14.3.7. F. Hoffmann-La Roche, Ltd.
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Financial Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. Business Strategies
      • 14.3.7.5. Recent Developments
    • 14.3.8. Merck KGaA
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. Business Strategies
      • 14.3.8.5. Recent Developments
    • 14.3.9. Regeneron Pharmaceuticals, Inc.
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Financial Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. Business Strategies
      • 14.3.9.5. Recent Developments
    • 14.3.10. Takeda Pharmaceutical Company Limited
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Financial Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. Business Strategies
      • 14.3.10.5. Recent Developments